228 related articles for article (PubMed ID: 37176118)
1. A Novel Anti-CD44 Variant 3 Monoclonal Antibody C
Suzuki H; Kitamura K; Goto N; Ishikawa K; Ouchida T; Tanaka T; Kaneko MK; Kato Y
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176118
[TBL] [Abstract][Full Text] [Related]
2. Development of a Novel Anti-CD44 Variant 6 Monoclonal Antibody C
Ejima R; Suzuki H; Tanaka T; Asano T; Kaneko MK; Kato Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835416
[TBL] [Abstract][Full Text] [Related]
3. Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C
Suzuki H; Ozawa K; Tanaka T; Kaneko MK; Kato Y
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189717
[TBL] [Abstract][Full Text] [Related]
4. Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C
Kudo Y; Suzuki H; Tanaka T; Kaneko MK; Kato Y
Antibodies (Basel); 2023 Apr; 12(2):. PubMed ID: 37218897
[TBL] [Abstract][Full Text] [Related]
5. Development of a Novel Anti-CD44 Monoclonal Antibody for Multiple Applications against Esophageal Squamous Cell Carcinomas.
Goto N; Suzuki H; Tanaka T; Asano T; Kaneko MK; Kato Y
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628345
[TBL] [Abstract][Full Text] [Related]
6. Development of a Novel Anti-CD44 Variant 4 Monoclonal Antibody C
Suzuki H; Tanaka T; Goto N; Kaneko MK; Kato Y
Curr Issues Mol Biol; 2023 Feb; 45(3):1875-1888. PubMed ID: 36975491
[TBL] [Abstract][Full Text] [Related]
7. A Novel Anti-CD44 Variant 9 Monoclonal Antibody C
Tawara M; Suzuki H; Goto N; Tanaka T; Kaneko MK; Kato Y
Curr Issues Mol Biol; 2023 Apr; 45(4):3658-3673. PubMed ID: 37185762
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a Novel Anti-CD44 Variant 10 Monoclonal Antibody C
Ishikawa K; Suzuki H; Kaneko MK; Kato Y
Curr Issues Mol Biol; 2023 Jun; 45(7):5248-5262. PubMed ID: 37504249
[TBL] [Abstract][Full Text] [Related]
9. Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C
Suzuki H; Goto N; Tanaka T; Ouchida T; Kaneko MK; Kato Y
Antibodies (Basel); 2023 Jul; 12(3):. PubMed ID: 37489367
[TBL] [Abstract][Full Text] [Related]
10. Epitope Mapping of the Anti-CD44 Monoclonal Antibody (C
Asano T; Kaneko MK; Takei J; Tateyama N; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Aug; 40(4):156-161. PubMed ID: 34283655
[TBL] [Abstract][Full Text] [Related]
11. Epitope Mapping of an Anti-CD44v4 Monoclonal Antibody (C
Suzuki H; Tawara M; Hirayama A; Goto N; Tanaka T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2024 Mar; ():. PubMed ID: 38507669
[TBL] [Abstract][Full Text] [Related]
12. Detection of high CD44 expression in oral cancers using the novel monoclonal antibody, C
Yamada S; Itai S; Nakamura T; Yanaka M; Kaneko MK; Kato Y
Biochem Biophys Rep; 2018 Jul; 14():64-68. PubMed ID: 29872736
[TBL] [Abstract][Full Text] [Related]
13. Epitope Mapping of the Anti-CD44 Monoclonal Antibody (C
Takei J; Asano T; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Oct; 40(5):219-226. PubMed ID: 34678095
[TBL] [Abstract][Full Text] [Related]
14. Development of a sandwich enzyme-linked immunosorbent assay for the detection of CD44v3 using exon v3- and v6-specific monoclonal antibody pairs.
Jeoung MH; Kim TK; Shim H; Lee S
J Immunol Methods; 2016 Sep; 436():22-8. PubMed ID: 27288967
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD44 standard and isoforms V3 and V6 in uterine smooth muscle tumors: a possible diagnostic tool for the diagnosis of leiomyosarcoma.
Poncelet C; Walker F; Madelenat P; Bringuier AF; Scoazec JY; Feldmann G; Darai E
Hum Pathol; 2001 Nov; 32(11):1190-6. PubMed ID: 11727257
[TBL] [Abstract][Full Text] [Related]
17. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
18. Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells.
Montero-Montero L; Renart J; Ramírez A; Ramos C; Shamhood M; Jarcovsky R; Quintanilla M; Martín-Villar E
Cells; 2020 Sep; 9(10):. PubMed ID: 33003440
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
Tran TA; Kallakury BV; Sheehan CE; Ross JS
Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy.
Aaltomaa S; Lipponen P; Viitanen J; Kankkunen JP; Ala-Opas M; Kosma VM
Eur Urol; 2000 Nov; 38(5):555-62. PubMed ID: 11096236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
